HighPoint Advisor Group’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $214K | Buy |
+14,995
| New | +$214K | 0.02% | 479 |
|
|
2021
Q3 | $189K | Buy |
11,515
+671
| +6% | +$11K | 0.02% | 522 |
|
|
2021
Q2 | $183K | Sell |
10,844
-531
| -5% | -$8.96K | 0.02% | 514 |
|
|
2021
Q1 | $196K | Buy |
11,375
+259
| +2% | +$4.46K | 0.02% | 463 |
|
|
2020
Q4 | $197K | Buy |
+11,116
| New | +$197K | 0.02% | 439 |
|
|
2020
Q2 | – | Sell |
-10,607
| Closed | -$186K | – | 374 |
|
|
2020
Q1 | $186K | Buy |
10,607
+50
| +0.5% | +$877 | 0.04% | 306 |
|
|
2019
Q4 | $212K | Buy |
10,557
+47
| +0.4% | +$944 | 0.04% | 321 |
|
|
2019
Q3 | $210K | Sell |
10,510
-227
| -2% | -$4.54K | 0.05% | 307 |
|
|
2019
Q2 | $184K | Buy |
+10,737
| New | +$184K | 0.04% | 328 |
|
|
2019
Q1 | – | Sell |
-10,563
| Closed | -$213K | – | 354 |
|
|
2018
Q4 | $213K | Buy |
+10,563
| New | +$213K | 0.06% | 282 |
|